###google_registration_done###
Intended for US audiences only.
  • wilate is supplied in a package with a single-dose vial of lyophilized powder and a vial of diluent (Water for Injection with 0.1% Polysorbate 80), together with a Mix2Vial™ transfer device, a 10-mL syringe, an infusion set, and two alcohol swabs.1
  • Each vial of wilate contains the labeled amount of IU of VWF:RCo activity as measured using a manual agglutination method, and IU of FVIII activity measured with a chromogenic substrate assay. Components used in the packaging of wilate contain no latex.1

References

1. wilate Full Prescribing Information. Paramus, NJ: Octapharma; rev 2016.

###event_chooseinsurance_120920###

COAG-0327
Indications and Important Safety Information for NUWIQ® and wilate®.
Indicaciones e Información de seguridad importante de NUWIQ® y wilate® .
Consulte la Información de prescripción completa de NUWIQ y instrucciones de uso, o Información de prescripción completa de wilate.
Indications and Important Safety Information for NUWIQ® [Antihemophilic Factor (Recombinant)]
Indicaciones e Información de seguridad importante de NUWIQ® [factor antihemofílico (recombinante)].
Consulte la Información de prescripción completa de NUWIQ. Instrucciones de uso
Indications and Important Safety Information for wilate® [von Willebrand Factor/Coagulation Factor VIII Complex (Human)].
Indicaciones e Información de seguridad importante de wilate® [complejo de factor de von Willebrand/factor VIII de la coagulación (humanos)].